Table 2:

Immune cell subtypes from sham and tumor-bearing mice

CD45+ cells	Wildtype Sham		Wildtype tumor-bear mice		Wildtype CGRPKO		CGRPKO tumor-bearing mice
	Tongue	Lymph node	Tongue	Lymph node	Tongue	Lymph node	Tongue	Lymph node
MOC1 oral cancer model
CD4+	0.93±0.03	16.5±2.28	2.34±0.27	20.44±5.04	0.71±0.07	18.52±2.39	3.72±1.15	23.75±3.95
CD8+	0.74±0.16	12.83±1.75	2.38±0.95	16.97±3.66	0.69±0.39	12.26±1.66	3.44±0.92	17.37±2.04
CD19+	1.38±0.18	32.44±3.08	1.73±0.43	53.99±9.78	0.72±0.02	48.00±5.17	1.07±0.33	48.70±4.09
NK1.1+	0.27±0.12	0.82±0.06	0.55±0.15	0.37±0.04	0.23±0.01	0.72±0.04	0.55±0.17	0.25±0.05
MOC2 oral cancer model
CD4+	7.10±2.11	12.47±1.09	9.84±2.92	14.86±1.32	5.76±0.53	11.00±1.42	38.77±9.11	17.54±5.42
CD8+	0.37±0.34	7.43±2.75	0.26±0.06	10.20±1.49	0.21±0.07	6.18±0.90	1.22±0.57	12.27±2.06
CD19+	2.08±1.36	60.24±4.73	3.75±1.90	70.14±3.61	2.41±1.86	60.11±2.64	7.44±1.35	67.9±6.64
NK1.1+	0.06±0.01	0.80±0.27	0.22±0.07	0.45±0.08	0.16±0.02	1.10±0.12	1.11±0.47	0.49±0.17

Data is presented as average percent of total CD45+ live cells counted ± standard deviation.